EVALUATION OF THE ROLE OF ADRB 2 IN THE PATHOGENESIS OF SYNTROPIA MYOCARDIAL INFARCTION AND METABOLIC SYNDROME

Article Sidebar

PDF
Published: 2023-09-20

Main Article Content

Musashaykhov U.Kh.
Andijan State Medical Institute (Andijan, Uzbekistan)
Boboev K.T.
Tashkent Medical Academy (Tashkent, Uzbekistan)
Nabieva D.A.
Republican Specialized Scientific and Practical Medical Center of Hematology of the Ministry of Health of the Republic of Uzbekistan (RSPMCG of the Ministry of Health of the Republic of Uzbekistan) (Tashkent, Uzbekistan)

Abstract

To study the genetic risk factors for MS formation by studying mutations of the Arg16/Gly and Gln27Glu polymorphisms in ADRBthe ADRB 2 gene..

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 3 No. 9 (2023): International Bulletin of Medical Sciences and Clinical Research

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

EVALUATION OF THE ROLE OF ADRB 2 IN THE PATHOGENESIS OF SYNTROPIA MYOCARDIAL INFARCTION AND METABOLIC SYNDROME. (2023). International Bulletin of Medical Sciences and Clinical Research, 3(9), 42-45. https://researchcitations.com/index.php/ibmscr/article/view/2597

References

Baturin A.K., Sorokina E.Yu., Pogozheva A.V., Makurina O.N., et al. The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity. Voprosy pitaniia [Problems of Nutrition]. 2012; Vol. 81 (2): 23–27.

Doncov A, Vasil'eva L. Gendernye antropometricheskie i gormonal'nye osobennosti pri metabolicheskom syndrome [Gender anthropometric and hormonal features in the metabolic syndrome]. Vrach. 2014;7:72-4. Russian.

Edgell H. et al. Central versus peripheral cardiovascular risk in metabolic syndrome. Front. Physiol. 2012; 3: 38—43.

Fahed, Gracia et al. “Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.” International journal of molecular sciences vol. 23,2 786. 12 Jan. 2022, doi:10.3390/ijms23020786

Kim M.K., Reaven G.M., Chen Y.I., et al. Hyperinsulinemia in individuals with obesity: Role of insulin clearance. Obesity (Silver Spring). 2015;23(12):2430-4. doi:10.1002/oby.21256.

Lemieux, Isabelle, and Jean-Pierre Després. “Metabolic Syndrome: Past, Present and Future.” Nutrients vol. 12,11 3501. 14 Nov. 2020.

Sung K.C., Reaven G. Fasting plasma triglyceride concentration: A possible approach to identify increased risk of statin-induced type 2 diabetes. Diab Vasc Dis Res. 2015;12(5):373-6. doi:10.1177/1479164115584275.

Saklayen, Mohammad G. “The Global Epidemic of the Metabolic Syndrome.” Current hypertension reports vol. 20,2 12. 26 Feb. 2018, doi:10.1007/s11906-018-0812-z.

Silveira Rossi, João Leonardo et al. “Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors.” Diabetes/metabolism research and reviews vol. 38,3 (2022): e3502. doi:10.1002/dmrr.3502.

Sherling, Dawn Harris et al. “Metabolic Syndrome.” Journal of cardiovascular pharmacology and therapeutics vol. 22,4 (2017): 365-367. doi:10.1177/1074248416686187